A detailed history of Paradigm Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Paradigm Capital Management, LLC holds 3,565 shares of AMGN stock, worth $1.05 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
3,565
Previous 3,085 15.56%
Holding current value
$1.05 Million
Previous $810,000 41.85%
% of portfolio
1.1%
Previous 1.19%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $148,502 - $161,942
480 Added 15.56%
3,565 $1.15 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $916 - $1,164
-4 Reduced 0.13%
3,085 $810,000
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $26,935 - $30,378
-120 Reduced 3.74%
3,089 $696,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $47,143 - $52,152
-215 Reduced 6.28%
3,209 $776,000
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $680,965 - $779,302
3,424 New
3,424 $770,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Paradigm Capital Management, LLC Portfolio

Follow Paradigm Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management, LLC with notifications on news.